Selleck Chemicals - Model A2001 -Ipilimumab (anti-CTLA-4)

Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor. MW : 148 kD.